236 results on '"Lorca, Rebeca"'
Search Results
2. STEMI in women. Life expectancy recovery after primary percutaneous coronary intervention
3. IAMCEST en mujeres. Recuperación de la expectativa de vida tras la intervención coronaria percutánea
4. Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR: A Propensity Score Analysis
5. Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart
6. STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study
7. Coexistencia de progresión transmural y lateral del frente de onda en el infarto de miocardio humano
8. IAMCEST, angioplastia primaria y recuperación de la esperanza de vida: ideas procedentes del estudio SurviSTEMI
9. Epigenetic Study of Cohort of Monozygotic Twins With Hypertrophic Cardiomyopathy Due to MYBPC3 (Cardiac Myosin-Binding Protein C).
10. Self-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprosthesis: Early outcomes
11. “Inherited cardiovascular disease mindset” can identify concealed inherited conditions at cardio-oncology evaluation: An opportunistic screening.
12. Natural History of Dilated Cardiomyopathy Due to c.77T>C (p.Val26Ala) in Emerin Protein
13. Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant
14. Entendimiento de la miocardiopatía hipertrófica mediante el estudio de una variante patogénica fundadora
15. Concealed Inherited Cardiomyopathies Detected in Cardio-Oncology Screening
16. PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal
17. Non compaction cardiomyopathy: Review of a controversial entity
18. Miocardiopatía no compactada: una miocardiopatía con controversias
19. Retrospective variant reclassification and resequencing in hypertrophic cardiomyopathy: A Reference Unit Centre Experience.
20. Retrospective variant reclassification and resequencing in hypertrophic cardiomyopathy: a reference unit centre experience.
21. Concealed Inherited Cardiomyopathies Detected in Cardio-Oncology Screening.
22. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence
23. Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients
24. Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia
25. Quadricuspid aortic valve surgical repair
26. Natural History of MYH7-Related Dilated Cardiomyopathy
27. Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry.
28. Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy
29. Association of the Genetic Variation in the Long Non-Coding RNA FENDRR with the Risk of Developing Hypertrophic Cardiomyopathy
30. Genetic Screening of a Large Panel of Genes Associated with Cardiac Disease in a Spanish Heart Transplanted Cohort
31. KCNH2 p.Gly262AlafsTer98: A New Threatening Variant Associated with Long QT Syndrome in a Spanish Cohort
32. The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort
33. Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males
34. IL17RA in early-onset coronary artery disease: Total leukocyte transcript analysis and promoter polymorphism (rs4819554) association
35. 10. MIOCARDIOPATÍAS HEREDITARIAS OCULTAS DETECTADAS EN EL CRIBADO CARDIOONCOLÓGICO
36. Frailty Assessment in a Cohort of Elderly Patients with Severe Symptomatic Aortic Stenosis: Insights from the FRailty Evaluation in Severe Aortic Stenosis (FRESAS) Registry
37. Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO‐SOR study
38. Premature STEMI in Men and Women: Current Clinical Features and Improvements in Management and Prognosis
39. Compound heterozygosity for PTPN11 variants in a subject with Noonan syndrome provides insights into the mechanism of SHP2 ‐related disorders
40. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
41. Clinical Implications and Gender Differences of KCNQ1 p.Gly168Arg Pathogenic Variant in Long QT Syndrome
42. Familial Hypercholesterolemia in Premature Acute Coronary Syndrome. Insights from CholeSTEMI Registry
43. Characterization of Left Ventricular Non-Compaction Cardiomyopathy
44. Functional mitral regurgitation: structural modifications with percutaneous valve repair with MitraClip
45. Long term follow up of percutaneous treatment for degenerated Mitroflow prosthesis with self-expanding transcatheter aortic valve implantation
46. Percutaneous treatment with Mitraclip for functional mitral regurgitation: medium-term follow up according to left ventricular function
47. Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart
48. Initial experience of a MitraClip valve repair program in Spain
49. Outcomes with percutaneous mitral repair vs. optimal medical treatment for functional mitral regurgitation: systematic review
50. Cardio-onco-hematology patients’ management in the context of the current COVID-19 pandemic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.